| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 9 | 2025 | 1350 | 2.910 |
Why?
|
| Selenium | 3 | 2024 | 25 | 2.270 |
Why?
|
| Selenocysteine | 2 | 2025 | 15 | 1.110 |
Why?
|
| Uridine | 1 | 2025 | 22 | 0.970 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2023 | 9 | 0.860 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2022 | 17 | 0.800 |
Why?
|
| RNA | 1 | 2025 | 422 | 0.740 |
Why?
|
| Inactivation, Metabolic | 1 | 2020 | 14 | 0.690 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 87 | 0.640 |
Why?
|
| Nerve Degeneration | 3 | 2008 | 72 | 0.580 |
Why?
|
| Alzheimer Disease | 4 | 2021 | 718 | 0.580 |
Why?
|
| Brain Neoplasms | 3 | 2021 | 308 | 0.540 |
Why?
|
| Glioblastoma | 2 | 2015 | 157 | 0.510 |
Why?
|
| Phytochemicals | 1 | 2016 | 22 | 0.510 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 89 | 0.500 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2015 | 1 | 0.480 |
Why?
|
| Ischemia | 2 | 2015 | 204 | 0.480 |
Why?
|
| Glycine | 1 | 2015 | 49 | 0.470 |
Why?
|
| Animals | 22 | 2025 | 20627 | 0.460 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 203 | 0.450 |
Why?
|
| Cyclin-Dependent Kinase 5 | 3 | 2008 | 9 | 0.440 |
Why?
|
| Neurodegenerative Diseases | 3 | 2021 | 143 | 0.440 |
Why?
|
| Oxidoreductases | 2 | 2024 | 64 | 0.410 |
Why?
|
| Selenoproteins | 2 | 2024 | 8 | 0.410 |
Why?
|
| Reactive Oxygen Species | 2 | 2025 | 224 | 0.390 |
Why?
|
| Cell Line, Tumor | 9 | 2021 | 1460 | 0.380 |
Why?
|
| Oxidative Stress | 2 | 2025 | 294 | 0.360 |
Why?
|
| Humans | 28 | 2025 | 62955 | 0.340 |
Why?
|
| DNA Damage | 2 | 2009 | 285 | 0.340 |
Why?
|
| Cell Cycle | 2 | 2009 | 393 | 0.340 |
Why?
|
| HIV Infections | 3 | 2023 | 965 | 0.320 |
Why?
|
| AIDS Vaccines | 2 | 2020 | 70 | 0.320 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 189 | 0.300 |
Why?
|
| Histone Deacetylases | 1 | 2008 | 65 | 0.290 |
Why?
|
| Cell Survival | 3 | 2021 | 573 | 0.290 |
Why?
|
| Serine | 2 | 2022 | 91 | 0.280 |
Why?
|
| Sirtuins | 1 | 2007 | 26 | 0.270 |
Why?
|
| Signal Transduction | 4 | 2023 | 3027 | 0.270 |
Why?
|
| Sirtuin 1 | 3 | 2013 | 27 | 0.260 |
Why?
|
| Mice | 12 | 2025 | 10826 | 0.260 |
Why?
|
| HIV-1 | 2 | 2023 | 719 | 0.250 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 660 | 0.250 |
Why?
|
| Olfactory Bulb | 1 | 2025 | 19 | 0.240 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2025 | 16 | 0.240 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2025 | 23 | 0.240 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 1 | 2025 | 3 | 0.240 |
Why?
|
| Multigene Family | 1 | 2025 | 99 | 0.240 |
Why?
|
| Energy Metabolism | 2 | 2025 | 378 | 0.230 |
Why?
|
| Tumor Microenvironment | 2 | 2016 | 152 | 0.230 |
Why?
|
| Mice, Nude | 3 | 2021 | 272 | 0.230 |
Why?
|
| Methylation | 1 | 2025 | 128 | 0.230 |
Why?
|
| Methyltransferases | 1 | 2025 | 62 | 0.230 |
Why?
|
| Neoplasm Metastasis | 1 | 2025 | 200 | 0.220 |
Why?
|
| Sulfides | 1 | 2024 | 22 | 0.220 |
Why?
|
| Ubiquinone | 1 | 2024 | 18 | 0.220 |
Why?
|
| Uridine Diphosphate Xylose | 1 | 2023 | 6 | 0.220 |
Why?
|
| Sphingosine | 1 | 2022 | 20 | 0.200 |
Why?
|
| Sphingolipids | 1 | 2022 | 24 | 0.200 |
Why?
|
| N-Methylaspartate | 1 | 2021 | 16 | 0.190 |
Why?
|
| Phosphotransferases | 2 | 2020 | 23 | 0.190 |
Why?
|
| Lipogenesis | 1 | 2022 | 68 | 0.190 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2007 | 507 | 0.190 |
Why?
|
| Memantine | 1 | 2021 | 23 | 0.180 |
Why?
|
| Neuroblastoma | 1 | 2021 | 52 | 0.180 |
Why?
|
| Histone Deacetylase 1 | 2 | 2013 | 18 | 0.180 |
Why?
|
| Phosphoproteins | 2 | 2019 | 220 | 0.180 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2021 | 29 | 0.180 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2021 | 87 | 0.180 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2021 | 46 | 0.180 |
Why?
|
| Ebolavirus | 1 | 2021 | 39 | 0.180 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2020 | 6 | 0.170 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2013 | 86 | 0.170 |
Why?
|
| Selenium Compounds | 1 | 2020 | 30 | 0.170 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2020 | 16 | 0.170 |
Why?
|
| Beclin-1 | 1 | 2019 | 22 | 0.160 |
Why?
|
| Viral Vaccines | 1 | 2020 | 49 | 0.160 |
Why?
|
| Anti-Retroviral Agents | 1 | 2020 | 76 | 0.160 |
Why?
|
| Antioxidants | 1 | 2021 | 252 | 0.160 |
Why?
|
| Neurons | 3 | 2013 | 919 | 0.160 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2019 | 57 | 0.160 |
Why?
|
| Viral Load | 1 | 2020 | 231 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 322 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 424 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 163 | 0.150 |
Why?
|
| Endosomes | 1 | 2019 | 178 | 0.150 |
Why?
|
| Pseudopodia | 1 | 2018 | 12 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 326 | 0.150 |
Why?
|
| Mice, Transgenic | 4 | 2013 | 1273 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 1195 | 0.140 |
Why?
|
| Metronidazole | 1 | 2017 | 9 | 0.140 |
Why?
|
| Rats | 3 | 2017 | 1980 | 0.140 |
Why?
|
| Anti-Ulcer Agents | 1 | 2016 | 9 | 0.130 |
Why?
|
| Dextrans | 1 | 2017 | 46 | 0.130 |
Why?
|
| Alanine | 1 | 2016 | 51 | 0.130 |
Why?
|
| Quinolones | 1 | 2016 | 29 | 0.130 |
Why?
|
| Gene Expression | 2 | 2011 | 838 | 0.130 |
Why?
|
| Actins | 1 | 2018 | 259 | 0.130 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 85 | 0.130 |
Why?
|
| Machine Learning | 1 | 2018 | 175 | 0.130 |
Why?
|
| Cell Movement | 1 | 2018 | 448 | 0.130 |
Why?
|
| Amyloid beta-Peptides | 2 | 2009 | 297 | 0.120 |
Why?
|
| Colon | 1 | 2017 | 145 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 129 | 0.120 |
Why?
|
| Nanoparticles | 1 | 2021 | 517 | 0.120 |
Why?
|
| Enzyme Activation | 3 | 2016 | 381 | 0.120 |
Why?
|
| Acetone | 1 | 2015 | 5 | 0.120 |
Why?
|
| Glycine Dehydrogenase (Decarboxylating) | 1 | 2015 | 3 | 0.120 |
Why?
|
| Pyruvaldehyde | 1 | 2015 | 6 | 0.120 |
Why?
|
| Pyruvate Kinase | 1 | 2015 | 11 | 0.120 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 42 | 0.120 |
Why?
|
| Biomarkers, Tumor | 2 | 2016 | 505 | 0.120 |
Why?
|
| Necrosis | 1 | 2015 | 144 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 209 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 67 | 0.110 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 17 | 0.110 |
Why?
|
| Pyrimidines | 1 | 2014 | 135 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 521 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2008 | 2157 | 0.100 |
Why?
|
| DNA End-Joining Repair | 1 | 2013 | 23 | 0.100 |
Why?
|
| Comet Assay | 2 | 2013 | 11 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2013 | 56 | 0.100 |
Why?
|
| Autoantigens | 1 | 2014 | 137 | 0.100 |
Why?
|
| Models, Biological | 1 | 2018 | 1181 | 0.100 |
Why?
|
| Phenotype | 1 | 2016 | 1198 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 267 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 198 | 0.100 |
Why?
|
| Acetylation | 2 | 2013 | 121 | 0.090 |
Why?
|
| Cerebral Cortex | 2 | 2013 | 258 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 3391 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2011 | 76 | 0.090 |
Why?
|
| Leucine | 1 | 2011 | 61 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 396 | 0.090 |
Why?
|
| Melanoma | 2 | 2011 | 332 | 0.090 |
Why?
|
| Epigenomics | 1 | 2011 | 62 | 0.090 |
Why?
|
| Transfection | 2 | 2011 | 692 | 0.090 |
Why?
|
| Melanocytes | 1 | 2011 | 80 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2011 | 75 | 0.080 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2010 | 46 | 0.080 |
Why?
|
| Thailand | 2 | 2020 | 98 | 0.080 |
Why?
|
| Female | 4 | 2020 | 32610 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 769 | 0.080 |
Why?
|
| PrPC Proteins | 1 | 2009 | 1 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 171 | 0.080 |
Why?
|
| Genes, cdc | 1 | 2009 | 15 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2009 | 63 | 0.080 |
Why?
|
| Memory | 1 | 2010 | 119 | 0.080 |
Why?
|
| Nerve Tissue | 1 | 2008 | 6 | 0.080 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 21 | 0.080 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2009 | 86 | 0.080 |
Why?
|
| Prosencephalon | 1 | 2008 | 37 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 37 | 0.080 |
Why?
|
| Autophagy | 1 | 2011 | 225 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 151 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2008 | 237 | 0.070 |
Why?
|
| Fear | 1 | 2008 | 70 | 0.070 |
Why?
|
| Genomics | 1 | 2011 | 368 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2020 | 739 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 146 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 384 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 364 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2009 | 411 | 0.070 |
Why?
|
| Stilbenes | 1 | 2007 | 48 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1184 | 0.070 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2007 | 144 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2014 | 1508 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 227 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 304 | 0.060 |
Why?
|
| Axons | 1 | 2025 | 123 | 0.060 |
Why?
|
| RNA Interference | 3 | 2013 | 619 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 1614 | 0.050 |
Why?
|
| Synapses | 1 | 2025 | 185 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2010 | 680 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 40 | 0.050 |
Why?
|
| Male | 6 | 2021 | 29602 | 0.050 |
Why?
|
| HIV Antibodies | 1 | 2023 | 144 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2019 | 981 | 0.050 |
Why?
|
| Drug Liberation | 1 | 2021 | 21 | 0.050 |
Why?
|
| Cell Line | 2 | 2018 | 2039 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 71 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2021 | 71 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 115 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 116 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2021 | 135 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 358 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2021 | 115 | 0.040 |
Why?
|
| Placebos | 1 | 2020 | 71 | 0.040 |
Why?
|
| Drug Substitution | 1 | 2020 | 42 | 0.040 |
Why?
|
| Withholding Treatment | 1 | 2020 | 41 | 0.040 |
Why?
|
| Survivors | 1 | 2021 | 170 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2020 | 45 | 0.040 |
Why?
|
| Particle Size | 1 | 2021 | 407 | 0.040 |
Why?
|
| Receptors, Transferrin | 1 | 2019 | 33 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 2181 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 894 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2021 | 264 | 0.040 |
Why?
|
| HIV | 1 | 2020 | 70 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 4658 | 0.040 |
Why?
|
| Vaccines, DNA | 1 | 2020 | 98 | 0.040 |
Why?
|
| Time Factors | 2 | 2021 | 3754 | 0.040 |
Why?
|
| Radiography | 1 | 2021 | 539 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2013 | 938 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2019 | 114 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 263 | 0.040 |
Why?
|
| Mutation | 1 | 2007 | 2599 | 0.040 |
Why?
|
| Potoroidae | 1 | 2018 | 1 | 0.040 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2018 | 2 | 0.040 |
Why?
|
| Intravital Microscopy | 1 | 2018 | 12 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 348 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1141 | 0.040 |
Why?
|
| Acute Disease | 1 | 2020 | 671 | 0.040 |
Why?
|
| Actin Cytoskeleton | 1 | 2018 | 76 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 90 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 901 | 0.040 |
Why?
|
| Indoles | 1 | 2018 | 110 | 0.040 |
Why?
|
| Protein Binding | 2 | 2014 | 1606 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2018 | 258 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 111 | 0.030 |
Why?
|
| Stomach Ulcer | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2016 | 32 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2016 | 43 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2016 | 53 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 76 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 942 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 384 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1003 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 1388 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 622 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 744 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1160 | 0.030 |
Why?
|
| Dihydrouracil Dehydrogenase (NADP) | 1 | 2014 | 3 | 0.030 |
Why?
|
| Software | 1 | 2018 | 384 | 0.030 |
Why?
|
| Mesoderm | 1 | 2014 | 85 | 0.030 |
Why?
|
| Etoposide | 1 | 2013 | 34 | 0.030 |
Why?
|
| Carcinoma | 1 | 2014 | 126 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2013 | 42 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 68 | 0.030 |
Why?
|
| Adult | 2 | 2020 | 16688 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 670 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2014 | 130 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 524 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 1554 | 0.020 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2011 | 1 | 0.020 |
Why?
|
| Ketoglutaric Acids | 1 | 2011 | 7 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 262 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 495 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2011 | 28 | 0.020 |
Why?
|
| Hippocampus | 1 | 2013 | 267 | 0.020 |
Why?
|
| Genes, Developmental | 1 | 2011 | 5 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 165 | 0.020 |
Why?
|
| Chloroquine | 1 | 2011 | 61 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 57 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 68 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 618 | 0.020 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2011 | 51 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2011 | 98 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 131 | 0.020 |
Why?
|
| ras Proteins | 1 | 2011 | 77 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 109 | 0.020 |
Why?
|
| Electrical Synapses | 1 | 2010 | 2 | 0.020 |
Why?
|
| CREB-Binding Protein | 1 | 2010 | 16 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2011 | 121 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 35 | 0.020 |
Why?
|
| Long-Term Potentiation | 1 | 2010 | 43 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2010 | 50 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2010 | 117 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2011 | 140 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 155 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 1595 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1997 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 201 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 875 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5608 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 6202 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 533 | 0.020 |
Why?
|
| Mitosis | 1 | 2010 | 218 | 0.020 |
Why?
|
| Mitochondria | 1 | 2011 | 370 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 852 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 662 | 0.020 |
Why?
|
| Proteins | 1 | 2011 | 751 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2011 | 756 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 17422 | 0.010 |
Why?
|